- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04855708
Patient Satisfaction With Virtual Visits
Evaluating Patient Satisfaction With 2-week Post-operative Virtual Visits Compared to In-office Visits: A Randomized Controlled Trial
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
This is a two arm, randomized non-inferiority clinical trial that will take place within the Minimally Invasive Gynecologic Surgery division in the Women's Health Institute of the Cleveland Clinic, Cleveland, OH.
Population - The Investigators will recruit patients undergoing benign minimally invasive hysterectomy (laparoscopic, robotic, and vaginal). Inclusion criteria include patients >18 years of age who are able to provide informed consent without assistance, speak English, and who have access to a phone or device equipped for virtual visits. Patients will be excluded if the staff surgeon determines they are inappropriate for virtual follow-up, if there is suspicion of malignancy, if they are unable to provide consent, or if they do not have access to technology that enables virtual visits.
Recruitment - Enrolled participants will be randomized to either a two-week virtual postoperative visit with a certified nurse practitioner (CNP) or a two-week in-office postoperative visit with a certified nurse practitioner (CNP) in a 1:1 allocation ratio. Block randomizations with block size of 4 will be assigned to nurse providers independently. Randomization schedules will be implemented by Redcap.
Data collection - The primary outcome of this study is patient satisfaction, as measured by the Press Ganey Medical Practice Survey and Medical Practice Telemedicine Survey. These questionnaires are currently sent to all patients by the Office of Patient Experience at our institution four days after their postoperative appointment. The investigators will provide verbal reminders about study participation and survey administration at the visit. Survey data will be obtained through the Office of Patient Experience and imported into RedCap. The secondary outcome is a new diagnosis of a postoperative complication requiring medical treatment (e.g. calling in of a prescription), an office visit with a CNP or MIGS surgeon, or an urgent care or ER visit. Complications include infection (urinary, pulmonary, wound, pelvic abscess, and bloodstream); thromboembolic events; bleeding; and issues with wound healing, such as dehiscence. Calvien-Dindo classification system for postoperative complications will be used. The Investigators will also look at no-show rates, visit times, and travel distance.
The investigators will collect basic demographic information from the EMR, including age, BMI, parity, and prior surgical history. Surgical indication, procedure performed, length of hospital stay, and perioperative outcomes (reoperation, readmission, unscheduled office or virtual visits (i.e. earlier than the scheduled 2 week visit), ED/urgent care visits, infection rates) will also be obtained. No-show rates will be obtained through the EMR. The investigators will also note if a planned virtual visit is unable to be completed due to technical difficulties, or is converted to a telephone visit. Travel distance from home to clinic site will be calculated using average travel time with minimal traffic based on participant's zip code using Google Maps.
The investigators will collect the reason for ineligibility for all patients deemed such by staff surgeons. All participants will be assigned a study number to facilitate de-identification of data. Data will be compiled in RedCap and securely stored on an encrypted server.
Statistical analysis
Power Calculation:
The Investigators hypothesized that patient satisfaction would be non-inferior for patients randomized to the postoperative virtual visit compared to those randomized to in-person virtual visit. Sample size of 70 patients in each arm is needed to achieve 90% power to detect a non-inferiority margin of -0.20. Allowing for a dropout rate of 20%, 88 patients will be recruited in each arm.
Analysis plan:
For the primary outcome, the Farrington-Manning score test for non-inferiority will be performed, for both intention-to-treat and per-protocol analyses. Approximately normally-distributed continuous measures will be summarized using means and standard deviations and will be compared using two-sample t-tests. Continuous measures that show departure from normality and ordinal measures will be summarized using medians and quartiles and will be compared using Wilcoxon rank sum tests. Categorical factors will be summarized using frequencies and percentages and will be compared using Pearson's chi-square tests or Fisher's exact tests.
All analyses will be done using SAS (version 9.4, The SAS Institute, Cary, NC) and a p < 0.05 will be considered statistically significant.
Study Timeline:
The MIGS division performs at least 20-30 hysterectomies per month. The Investigators estimate to achieve our target recruitment in 7-8 months.
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Catherine Keller, M.D.
- Phone Number: 216-444-6337
- Email: kellerc2@ccf.org
Study Locations
-
-
Ohio
-
Cleveland, Ohio, United States, 44195
- Recruiting
- Cleveland Clinic
-
Contact:
- Catherine Keller, M.D.
- Phone Number: 216-444-6337
- Email: kellerc2@ccf.org
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion criteria
- Age greater than 18
- Able to provide informed consent without assistance
- English speaking
- Access to phone or device equipped for virtual visit
Exclusion criteria
- Surgeon determines participant is not a good candidate for virtual follow-up visit
- Suspicion of malignancy
- Unable to provide informed consent
- No access to technology for virtual visit
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Virtual visit
Patients will have 2-week post-operative virtual visit
|
Patients randomized to this group will have a virtual 2-week post-operative visit
|
Active Comparator: Office visit
Patients will return to the office for a 2-week post-operative visit
|
Patients randomized to this group will have a in-person 2-week post-operative visit
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Patient satisfaction at 2-weeks
Time Frame: 2-weeks
|
The Press Ganey Medical Practice Survey is used to provide feedback on improving aspects of the clinic experience.
It measures access, moving through the visit, nurse/assistant, care provider, personal issues and overall assessment.
The scale exists from 1-5 (1=very poor, 5=very good)
|
2-weeks
|
Patient satisfaction at 2-weeks
Time Frame: 2-weeks
|
The Press Ganey Medical Practice Telemedicine Survey is used to provide feedback on utilizing remote delivery of healthcare services.
It measures access, care provider, telemedicine technology and overall access.
The scale exists from 1-5 (1=very poor, 5=very good)
|
2-weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Post-operative complications
Time Frame: 2-weeks
|
Complications include infection (urinary, pulmonary, wound, pelvic abscess, bloodstream); thromboembolic events; bleeding; and issues with wound healing, such as dehiscence
|
2-weeks
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Unscheduled visits
Time Frame: 2-weeks
|
Unscheduled office visits with CNP or MIGS surgeon, urgent care or ER visits
|
2-weeks
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Rosanne Kho, M.D., The Cleveland Clinic
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- 21-141
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Satisfaction, Patient
-
Shaukat Khanum Memorial Cancer Hospital & Research...Enrolling by invitationSatisfaction, Patient | SatisfactionPakistan
-
Cedars-Sinai Medical CenterTerminated
-
Universitair Ziekenhuis BrusselUnknownPatient Satisfaction | Patient PreferenceBelgium
-
HaEmek Medical Center, IsraelUnknownPatient Satisfaction | Patient Compliance
-
Acibadem UniversityCompletedPatient Satisfaction | Patient Relations, NurseTurkey
-
Samsun UniversityRecruiting
-
University of UtahActive, not recruitingPatient SatisfactionUnited States
-
Fatma mahannaCompleted
-
Medical University of ViennaCompletedPatient SatisfactionAustria
-
Ziekenhuis Oost-LimburgCompleted
Clinical Trials on Virtual visit
-
University of RochesterDavis Phinney FoundationCompleted
-
Case Comprehensive Cancer CenterWithdrawn
-
CAMC Health SystemSarah & Pauline Maier Foundation, Inc.; WVCTSINot yet recruitingVascular Diseases
-
The Cleveland ClinicActive, not recruitingSatisfaction, PatientUnited States
-
Wake Forest University Health SciencesAmerican College of SurgeonsCompletedCholecystectomy, Laparoscopic | Appendectomy, Laparoscopic | Cholecystectomy, RoboticUnited States
-
The Cleveland ClinicCompletedHeart Failure, Systolic | Heart Failure With Preserved Ejection FractionUnited States
-
The Cleveland ClinicCompleted
-
Sakarya UniversityNot yet recruitingSatisfaction | Attachment | Virtual
-
Brigham and Women's HospitalTerminatedHeart Failure | Stroke | Hypertension | Diabetes Mellitus | Hyperlipidemia | BPHUnited States